Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |